Data on the safety and tolerability of revefenacin, in patients with moderate to very severe chronic obstructive pulmonary disease

por Donohue, James, Kerwin, Edward, Sethi, Sanjay, Haumann, Brett, Pendyala, Srikanth, Dean, Lorna, Barnes, Chris N., Moran, Edmund J., Crater, Glenn
Publicado 2019

Maintained therapeutic effect of revefenacin over 52 weeks in moderate to very severe Chronic Obstructive Pulmonary Disease (COPD)

por Donohue, James F., Kerwin, Edward, Sethi, Sanjay, Haumann, Brett, Pendyala, Srikanth, Dean, Lorna, Barnes, Chris N., Moran, Edmund J., Crater, Glenn
Publicado 2019

Safety of bloodless autologous stem cell transplantation in Jehovah's Witness patients

por Beck, Alyssa, Lin, Robert, Reza Rejali, Ali, Rubens, Muni, Paquette, Ronald, Vescio, Robert, Merin, Noah, Guerrero, Margarita, Federizo, Yvette, Lua, Michelle, Uy, Leticia, Hernandez, Lorraine, Allred, Mohana, Legaspi, Ronald, Leaverton, Melissa, Oliva, Sara, Castillo, Rhona, Dean, Lorna, Bourke, Jennifer, Cooper, Sara, Gharapetian, Seda, Causin, Jose, Lopiccolo, Christopher, Ann Snoussi, Laura, VanStrien, Patricia, Lill, Michael, Linhares, Yuliya P.
Publicado 2020